8RT-20061-98813
2 vaccinations
3 coded responses
21 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 787 / TX
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Dose 1 — Moderna
-
2021-01-09
Registered in v-safe
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
-
2021-01-22
Survey response — day 14, dose 1MedDRA: Injection site rash — Feeling: GoodFree text: Rash at injection site. Lasted for 2 days. Went away.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-29
-
2021-02-03
Dose 2 — Moderna
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Itching · Fever · Chills, Headache, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-03-17
-
2021-05-05
Survey response — 3 months, dose 2MedDRA: Delivery — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Delivery of babyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-05
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-02
- 2021-08-04
-
2022-02-03
Survey response — 12 months, dose 2MedDRA: Nasopharyngitis — Feeling: GoodFree text: Various coldsMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Moderna | |
| 2 | 2021-02-03 | Moderna |
Call center
1 call center case
1 unsuccessful
Free text
Release 2 — day 14, dose 1
Symptoms: Rash at injection site. Lasted for 2 days. Went away.
Release 8 — 3 months, dose 2
Symptoms: Delivery of baby
Release 11 — 12 months, dose 2
Symptoms: Various colds
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Delivery | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release